CADDRA Blog

2023

• 12/07/2023 - Foquest is now covered on the Nova Scotia Formulary
• 11/03/2023 - FOQUEST now on the Alberta Drug Benefit List
• 11/01/2023 - Vyvanse added to innoviCares program
• 11/01/2023 - New ADHD meds on Alberta Drug Benefit List
• 09/13/2023 - New Nova Scotia Pilot Program to Address ADHD and ASD Wait Lists
• 09/08/2023 - FOQUEST has now been included on the Newfoundland and Labrador Prescription Drug Program (NLPDP) as of Aug 30, 2023
• 08/09/2023 - Advocacy Update – Meetings with Provincial Ministers – July/August 2023
• 08/09/2023 - Risks Associated With Undiagnosed ADHD and/or Autism: A Mixed-Method Systematic Review
• 07/05/2023 - Double-Blind, Sham-Controlled Randomized Trial Testing the Efficacy of fMRI Neurofeedback on Clinical and Cognitive Measures in Children With ADHD
• 06/27/2023 - Advocacy Update – June 2023 – Meetings with Provincial Ministers
• 06/12/2023 - Advocacy Update – April/May 2023 – Meetings with Provincial Ministers
• 04/27/2023 - FOQUEST has now been included on the Ontario Drug Benefit (ODB) formulary as of April 28, 2023
• 04/13/2023 - FOQUEST has now been included on the Quebec formulary as of April 2023
• 04/11/2023 - Newfoundland and Labrador Expand Scope of Practice for Pharmacists – Improves Access to ADHD Medications and Health Care
• 04/05/2023 - Help support Bill C-329 – The National Framework on Attention Deficit Hyperactivity Disorder Act
• 03/13/2023 - Treatment Update – STRATTERA® (atomoxetine capsules) to be discontinued as of March 2023
• 03/13/2023 - Treatment Update – STRATTERA® (atomoxetine capsules) to be discontinued as of March 2023

2022

• 06/08/2022 - The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders
• 04/14/2022 - PEI funds the first Provincial Adult ADHD Program in the country
• 03/16/2022 - Action Plan: Creating Equitable Access to ADHD Care in Canada
• 03/02/2022 - FOQUEST has now been included on the Saskatchewan formulary as of March 2022
• 02/16/2022 - Driving Performance and Cannabis Users’ Perception of Safety: A Randomized Clinical Trial
• 01/12/2022 - A program to improve the assessment of a child for attention deficit hyperactivity disorder
• 01/11/2022 - CONCERTA has now been updated to full benefit status in Nova Scotia, New Brunswick and Newfoundland & Labrador
• 01/11/2022 - FOQUEST has now been included on the Manitoba formulary as of November 2021

2021

• 12/08/2021 - Sleep quality in children and adolescents with attention-deficit and hyperactivity disorder
• 12/01/2021 - Childhood ADHD Symptoms, Parent Emotion Socialization, and Adolescent Peer Problems: Indirect Effects Through Emotion Dysregulation
• 11/24/2021 - Diagnostic and Medication Treatment Disparities in African American Children with ADHD: a Literature Review
• 11/17/2021 - Variable Patterns of Remission from ADHD in the Multimodal Treatment Study of ADHD
• 11/10/2021 - Time Perception is a Focal Symptom of Attention-Deficit/Hyperactivity Disorder in Adults
• 11/03/2021 - Annual Research Review: Attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions
• 10/27/2021 - alpha2-Adrenergic Agonists or Stimulants for Preschool-Age Children with Attention-Deficit/Hyperactivity Disorder
• 10/20/2021 - An Individual Participant Data Meta-analysis: Behavioral Treatments for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
• 10/13/2021 - Improving Care Management in Attention-Deficit/Hyperactivity Disorder: An RCT
• 10/08/2021 - Contributions of Friends’ Problem Behaviors to Friendship Quality in a Sample of Children with ADHD.
• 09/29/2021 - The association between symptom severity and theory of mind impairment in children with attention deficit/hyperactivity disorder
• 09/21/2021 - A Placebo-Controlled Trial of Lisdexamfetamine in the Treatment of Comorbid Sluggish Cognitive Tempo and Adult ADHD
• 09/15/2021 - Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: A systematic review and meta-analysis
• 09/13/2021 - CADDRA and CADDAC call for all Federal Parties to Address Inequities to Access to Mental Health Care in Canada
• 09/08/2021 - Intentional Discontinuation of Psychostimulants Used to Treat ADHD in Youth: A Review and Analysis
• 09/01/2021 - Placebo and nocebo responses in randomized, controlled trials of medications for ADHD: a systematic review and meta-analysis.
• 08/25/2021 - Comparing the initial impact of COVID-19 on burden and psychological distress among family caregivers of children with and without developmental disabilities.
• 08/18/2021 - A Quality Improvement Initiative to Improve ADHD Follow-up rates Using School-based Telemedicine.
• 08/11/2021 - Half of the children with overweight or obesity and ADHD reach normal weight with stimulants
• 08/04/2021 - Predictors of Treatment Engagement and Outcome among Adolescents with ADHD: An Integrative Data Analysis.
• 07/28/2021 - ASD symptoms in adults with ADHD: a preliminary study using the ADOS-2.
• 07/21/2021 - Sleep-related traits and ADHD comorbidity: shared genetic risk factors, molecular mechanisms, and causal effects
• 07/14/2021 - ADHD with developmental coordination disorder: 24-year follow-up of a population-based sample
• 07/07/2021 - Evaluation of a structured skills training group for adolescents with attention deficit/hyperactivity disorder: a randomized controlled trial
• 06/30/2021 - Similarity of subjective symptoms between autism spectrum disorder and ADHD in adults: Preliminary findings.
• 06/23/2021 - Comparable emotional dynamics in women with ADHD and borderline personality disorder
• 06/16/2021 - Intervention response among preschoolers with ADHD: The role of emotion understanding
• 06/09/2021 - Screening for adult ADHD using brief rating tools: What can we conclude from a positive screen? Some caveats.
• 06/02/2021 - Which factors determine clinicians’ policy and attitudes towards medication and parent training for children with ADHD?
• 05/26/2021 - Efficacy of cognitive behavioural therapy in medicated adults with attention-deficit/hyperactivity disorder in multiple dimensions: a randomised controlled trial.
• 05/19/2021 - Digital health interventions (DHI) for the treatment of attention deficit hyperactivity disorder (ADHD) in children
• 05/12/2021 - Prospective impact of COVID-19 on mental health functioning in adolescents with and without ADHD: protective role of emotion regulation abilities
• 05/05/2021 - The neurodevelopmental nature of attention-deficit hyperactivity disorder in adults
• 04/28/2021 - ADHD and risk for subsequent adverse childhood experiences: understanding the cycle of adversity
• 04/22/2021 - CADDRA and CADDAC Call on Provinces to prioritize individuals with ADHD in COVID-19 vaccination rollout
• 04/21/2021 - A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD) a randomized controlled trial
• 04/14/2021 - Emotion recognition and mind wandering in adults with attention deficit hyperactivity disorder or autism spectrum disorder
• 04/07/2021 - Time knowledge impairments in children with ADHD
• 03/31/2021 - Time Perception Deficits in Children and Adolescents with ADHD: A Meta-analysis
• 03/24/2021 - Defining the role of exposure to ACEs in ADHD: Examination in a national sample of US children
• 03/17/2021 - Medications for ADHD in individuals with or without coexisting autism spectrum disorder: analysis of data from the Swedish prescribed drug register
• 03/10/2021 - Unique Associations between Specific Attention-Deficit Hyperactivity Disorder Symptoms and Related Functional Impairments
• 03/03/2021 - The Unique Effects of Maternal ADHD Symptoms and Emotion Dysregulation on Parenting Behavior
• 02/24/2021 - Physical Health, Media Use, and Mental Health in Children and Adolescents with ADHD During the COVID-19 Pandemic in Australia
• 02/17/2021 - The Course of ADHD during Pregnancy
• 02/10/2021 - The Effects of ADHD Teacher Training Programs on Teachers and Pupils: A Systematic Review and Meta-Analysis.
• 02/03/2021 - Theory of Mind in ADHD. A Proposal to Improve Working Memory through the Stimulation of the Theory of Mind
• 01/27/2021 - Chronotypes and trauma reactions in children with ADHD in home confinement of COVID-19: full mediation effect of sleep problems
• 01/20/2021 - College Readiness: Differences Between First-Year Undergraduates with and Without ADHD
• 01/13/2021 - Chronic Physical Activity for ADHD and/or Autism Spectrum Disorder in Children: A Meta-Analysis of Randomized Controlled Trials
• 01/06/2021 - Effects of chronotherapy on circadian rhythm and ADHD symptoms in adults
• 01/04/2021 - Helping Clinicians to Detect ODD in Children with ADHD in Clinical Settings

2020

• 12/23/2020 - Attention Deficit Hyperactivity Disorder Symptoms in Young Children with Autism Spectrum Disorder
• 12/16/2020 - Remote Learning During COVID-19
• 12/09/2020 - Relative Frequency of Psychiatric, Neurodevelopmental, and Somatic Symptoms as Reported by Mothers of Children with Autism Compared with ADHD and Typical Samples
• 12/02/2020 - Mindful Parenting Behaviors and Emotional Self-Regulation in Children with ADHD and Controls
• 11/25/2020 - Attention-deficit/hyperactivity disorder medication and risk of suicide attempt: A meta-analysis of observational studies
• 11/18/2020 - Feasibility trial of the dialectical behavior therapy skills training group as add-on treatment for adults with attention-deficit/hyperactivity disorder
• 11/11/2020 - Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD)or/and autism spectrum disorder (ASD)
• 11/04/2020 - Social and Economic Costs of Attention-Deficit/Hyperactivity Disorder Across the Lifespan
• 10/28/2020 - Revisiting the Effect of Varying the Number of Response Alternatives in Clinical Assessment: Evidence From Measuring ADHD Symptoms
• 10/21/2020 - Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers’ ADHD, Parenting Behavior, and At-Risk Children
• 10/14/2020 - An RCT of an Online Parenting Program for Parents of Preschool-Aged Children with ADHD Symptoms
• 10/13/2020 - Cannabis and ADHD – A CADDRA Policy Statement
• 10/07/2020 - Feasibility, Acceptability, and Effectiveness of a New Cognitive-Behavioral Intervention for College Students with ADHD
• 09/30/2020 - Do Parents’ ADHD Symptoms Affect Treatment for their Children?
• 09/23/2020 - Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
• 09/16/2020 - Efficacy and Safety of Guanfacine Extended-Release in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
• 09/09/2020 - Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder.
• 09/02/2020 - Comparison of accommodations and interventions for youth with ADHD: A randomized controlled trial.
• 08/26/2020 - Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
• 08/19/2020 - ADHD as a Risk Factor for Infection with COVID-19
• 08/12/2020 - Perspective on Melatonin Use for Sleep Problems in Autism and Attention-Deficit Hyperactivity Disorder: A Systematic Review of Randomized Clinical Trials
• 08/05/2020 - Adult attention deficit hyperactivity disorder clinic: An inter-professional collaboration
• 07/29/2020 - Effect of Parent Training on Health-Related Quality of Life in Preschool Children with Attention-Deficit/Hyperactivity Disorder: A Secondary Analysis of Data from a Randomized Controlled Trial
• 07/22/2020 - Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study
• 07/15/2020 - Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects
• 07/08/2020 - Primary Care Management of Children with Attention-Deficit/Hyperactivity Disorder Appears More Assertive Following Brief Psychiatric Intervention Compared with Single Session Consultation
• 07/03/2020 - What Is the Link Between Attention-Deficit/Hyperactivity Disorder and Sleep Disturbance? A Multimodal Examination of Longitudinal Relationships and Brain Structure Using Large-Scale Population-Based Cohorts
• 06/26/2020 - EndeavorRx ADHD Video Game: A CADDRA Information Sheet
• 06/24/2020 - Frequency and individual severity of arterial blood pressure changes in children and adolescents with attention-deficit / hyperactivity disorder treated with methylphenidate hydrochloride: a prospective non-interventional study
• 06/17/2020 - Parenting stress and family resilience affect the association of adverse childhood experiences with children’s mental health
• 06/11/2020 - British Columbia Pharmacare Update
• 06/10/2020 - Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure
• 06/03/2020 - Caffeine Use and Associations with Sleep in Adolescents with and without ADHD
• 05/27/2020 - Adherence to lifestyle recommendations and ADHD: A population-based study of children aged 10-11 years
• 05/20/2020 - Research Review The strength of the genetic overlap between ADHD and other psychiatric symptoms – a systematic review and meta-analysis
• 05/13/2020 - Impact of sleep restriction on affective functioning in adolescents with attention-deficit/hyperactivity disorder
• 05/06/2020 - Interventions for Adolescents with ADHD to Improve Peer Social Functioning: A Systematic Review and Meta-Analysis
• 04/29/2020 - Emotion dysregulation in adults with attention deficit hyperactivity disorder a meta-analysis
• 04/22/2020 - Observation and comparison of social abilities in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder children
• 04/08/2020 - Cumulative social disadvantage and risk of attention deficit hyperactivity disorder: Results from a nationwide cohort study
• 04/01/2020 - An innovative SMS intervention to improve adherence to stimulants in children with ADHD: Preliminary findings
• 03/27/2020 - Vyvanse® Chewable Tablet added to Ontario Formulary
• 03/25/2020 - Interventions for Adolescents with ADHD to Improve Peer Social Functioning
• 03/25/2020 - New Health Canada temporary exemptions for prescriptions of controlled substances, including psychostimulants
• 03/18/2020 - Attention Deficit Hyperactivity Disorder – ADHD
• 03/11/2020 - Impact of ADHD on Household Chores
• 03/04/2020 - Executive and Daily Life Functioning Influence the Relationship between ADHD and Mood Symptoms in University Students
• 02/26/2020 - Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults…
• 02/20/2020 - The Role of Sleep Duration and Sleep Problems during Childhood in the Development of ADHD in Adolescence: Findings From a Population-Based Birth Cohort
• 02/12/2020 - Academic impairment among high school students with ADHD: The role of motivation and goal-directed executive functions
• 02/05/2020 - Telemedicine in the Management of ADHD: Literature Review of Telemedicine in ADHD
• 01/29/2020 - Recent Trends in the Prescribing of ADHD Medications in Canadian Primary Care
• 01/28/2020 - Intuniv added to Ontario Formulary
• 01/22/2020 - Academic Motivation Deficits in Adolescents with ADHD and Associations with Academic Functioning
• 01/15/2020 - The Association between Autism Symptoms and Child Functioning in a Sample with ADHD Recruited from the Community
• 01/08/2020 - Neurological and Psychiatric Adverse Effects of Long-Term Methylphenidate Treatment in ADHD: A Map of the Current Evidence
• 01/02/2020 - Autistic Spectrum Disorder Symptoms in Children and Adolescents with ADHD: a Meta-Analytical Review

2019

• 12/18/2019 - Associations between Family and Community Protective Factors and Attention-Deficit Hyperactivity Disorder Outcomes among US Children
• 12/11/2019 - Trajectories of Depressive Symptoms in Adolescence: The Interplay of Maternal Emotion Regulation Difficulties and Youth ADHD Symptomatology
• 12/04/2019 - Suicidal Behaviour among Persons with Attention-Deficit Hyperactivity Disorder
• 11/27/2019 - Antipsychotic Treatment among Youths with Attention-Deficit / Hyperactivity Disorder
• 11/20/2019 - Effects and clinical feasibility of a behavioral treatment for sleep problems in adult attention deficit hyperactivity disorder (ADHD): a pragmatic within-group pilot evaluation
• 11/13/2019 - The Association between Child Abuse and Emotional and Behavioral Problems in Chinese School-Aged Boys with Attention Deficit Hyperactivity Disorder
• 11/06/2019 - A comparison of efficacy between cognitive behavioral therapy (CBT) and CBT combined with medication in adults with ADHD
• 10/30/2019 - Intraindividual variability of sleep/wake patterns in adolescents with and without attention-deficit/hyperactivity disorder
• 10/23/2019 - The relationship between chronotype and obesity in children and adolescent with attention deficit hyperactivity disorder
• 10/16/2019 - Impact of a behavioral intervention, delivered by pediatricians or psychologists, on sleep problems in children with ADHD: a cluster-randomized, translational trial
• 10/09/2019 - Emotion Regulation in Participants Diagnosed With Attention Deficit Hyperactivity Disorder, Before and After an Emotion Regulation Intervention
• 10/02/2019 - Cohort Change in the Prevalence of ADHD among U.S. Adults Evidence of a Gender-Specific Historical Period Effect
• 09/25/2019 - Adverse Drug Reactions Related to Mood and Emotion in Pediatric Patients Treated for ADHD
• 09/18/2019 - Clinical Implications of the Perception of Time in Attention Deficit Hyperactivity Disorder (ADHD): A Review
• 09/11/2019 - Clinical correlates of mind wandering in adults with ADHD
• 09/04/2019 - A multi-factorial perspective on ADHD and ODD in school-aged children: What is the role of cognitive regulation, temperament, and parental support?
• 08/28/2019 - Subclinical Scores in Self-Report Based Screening Tools for Attention Deficits Correlate with Cognitive Traits in Typical Evening-Type Adults Tested in the Morning
• 08/21/2019 - Slow Processing Speed and Sluggish Cognitive Tempo in Pediatric ADHD: Evidence for Differentiation of Functional Correlates
• 08/14/2019 - Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study
• 08/07/2019 - Evaluation of a structured skills training group for adolescents with ADHD – study protocol of a randomized controlled trial
• 07/31/2019 - Beyond stimulants: a systematic review of randomized controlled trials assessing novel compounds for ADHD
• 07/25/2019 - CADDRA Summary: Advisory Council on the Implementation of National Pharmacare Report
• 07/24/2019 - Bending the Curve: A Community-Based Behavioral Parent Training Model to Address ADHD-Related Concerns in the Voluntary Sector in Denmark
• 07/17/2019 - Expectancy Effects on Self-Reported Attention-Deficit/Hyperactivity Disorder Symptoms in Simulated Neurofeedback: A Pilot Study
• 07/11/2019 - First Chewable ADHD Treatment Authorized by Health Canada
• 07/10/2019 - New indication and new reimbursement codes in Quebec
• 07/10/2019 - Association between sleep duration and attention-deficit hyperactivity disorder: A systematic review and meta-analysis of observational studies
• 07/03/2019 - A Novel Text Message Intervention to Improve Adherence to Stimulants in Adults with ADHD
• 06/26/2019 - Long-term Effects of Multimodal Treatment on Adult ADHD Symptoms: Follow-up Analysis of the COMPAS Trial
• 06/12/2019 - A 9-Year Follow-Up of Attention-Deficit/Hyperactivity Disorder in a Population
• 06/05/2019 - New Formulations of Stimulants: An Update for Clinicians
• 06/04/2019 - Toronto District School Board funding cuts to support services – psychology staff
• 05/29/2019 -  Sleep and daytime sleepiness in adolescents with and without ADHD: differences across ratings, daily diary, and actigraphy
• 05/22/2019 - Piloting a Sequential, Multiple Assignment, Randomized Trial for Mothers with Attention-Deficit/Hyperactivity Disorder and Their At-Risk Young Children
• 05/15/2019 - Attention-Deficit/Hyperactivity Disorder Symptoms are Associated with Lower Adaptive Behavior Skills in Children with Autism
• 04/10/2019 - Evidence of concurrent and prospective associations between early maltreatment and ADHD through childhood and adolescence
• 04/10/2019 - New England Journal of Medicine (NEJM) ADHD Medication and Psychosis Study
• 04/03/2019 - Shortened Sleep Duration Causes Sleepiness, Inattention, and Oppositionality in Adolescents with ADHD
• 03/27/2019 - Attention-Deficit/Hyperactivity Disorder, School Performance, and Effect of Medication.
• 03/20/2019 - Prescribing for young people with attention deficit hyperactivity disorder in UK primary care
• 03/14/2019 - Foquest Receives Approval for Expanded Indication for Children and Adolescents with ADHD
• 03/13/2019 - Sustained impact of a sleep intervention and moderators of treatment outcome for children with ADHD
• 03/06/2019 - Predictors and Trajectories of Response to the Homework, Organization, and Planning Skills (HOPS) Intervention for Adolescents with ADHD
• 03/04/2019 - Disability Tax Credit Survey – An Update
• 02/27/2019 - Dimensions of Impulsivity
• 02/26/2019 - Treatment Patterns and Costs among Children with ADHD
• 02/26/2019 - Cannabis use and driving-related performance
• 01/16/2019 - Healthcare Professionals: Please Complete our Disability Tax Credit Survey

2018

• 04/25/2018 - Update on BC College’s Stimulant Prescribing Standards
• 02/28/2018 - BC Patients Urged to Support CADDAC Campaign
• 02/28/2018 - New Medication Option for adults with ADHD in Canada

2017

• 03/22/2017 - Invitation to 2017 PAS Spring Conference and CADDRA ADHD Institute Workshops

2016

• 10/28/2016 - Health Canada Product Monograph Update: Intuniv (guanfacine)
• 05/05/2016 - BC Physicians: Campaign to Add Physician Voice to PharmaCare ADHD Review

2015

• 12/18/2015 - Public funding disparity across provinces for ADHD medication
• 12/18/2015 - ODPRN Report Released in Ontario
• 12/08/2015 - Call to BC Government: Extend Coverage to All Long-Acting Meds!
• 11/10/2015 - New CADDRA ADHD Transition Form
• 11/04/2015 - Request for Intuniv Inclusion in Ontario Drug Formulary
• 10/27/2015 - Dispelling the Myths & Misinformation about ADHD
• 09/24/2015 - BC ADHD Advocacy Meeting: Friday, 16 October
• 04/02/2015 - CADDRA Response to Health Canada Alert

2013

• 11/01/2013 - CADDRA Rebuttal in National Post
• 11/01/2013 - New AAP Guidelines on ADHD
• 11/01/2013 - New Prescribing Regulations for ADHD Medication in Ontario
• 11/01/2013 - New Health Canada Information on Strattera
• 11/01/2013 - CADDRA Guide to Provincial Formularies: Long-Acting Medications
• 11/01/2013 - Vyvanse Approved on Ontario Formulary
• 11/01/2013 - Vyvanse now approved for all ages by Health Canada
• 11/01/2013 - New long-acting psychostimulants for ADHD treatment launched in Canada
• 11/01/2013 - Cardiac Risk Assessment before Stimulant Medication Use

2012

• 09/26/2012 - CADDRA Response to Toronto Star

2011

• 08/16/2011 - CADDRA Support for CPA Position Paper on Newer Medications

2010

• 06/03/2010 - CADDRA response to new ADHD Generic Medication: Novo-Methylphenidate ER-C

2009

• 11/19/2009 - CADDRA Response to Sudden Death and Use of Stimulant Medications Study
• 11/19/2009 - Revision of Biphentin starting doses